RECURRENT MYCOSIS FUNGOIDES
Clinical trials for RECURRENT MYCOSIS FUNGOIDES explained in plain language.
Never miss a new study
Get alerted when new RECURRENT MYCOSIS FUNGOIDES trials appear
Sign up with your email to follow new studies for RECURRENT MYCOSIS FUNGOIDES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Virus-Based therapy targets Hard-to-Treat blood cancers
Disease control Recruiting nowThis early-phase trial tests a genetically modified virus (VSV-IFNβ-NIS) alone or with chemotherapy and immunotherapy drugs in people with blood cancers like multiple myeloma, acute myeloid leukemia, and lymphomas that have returned or not responded to treatment. The virus is des…
Matched conditions: RECURRENT MYCOSIS FUNGOIDES
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New study aims to decode drug rash vs. disease worsening in rare skin cancers
Knowledge-focused Recruiting nowThis study looks at a common side effect—rash—from the drug mogamulizumab in people with mycosis fungoides or Sezary syndrome, two rare types of skin lymphoma. The rash can look like the cancer itself, leading doctors to stop treatment too early. Researchers will study 100 adults…
Matched conditions: RECURRENT MYCOSIS FUNGOIDES
Sponsor: City of Hope Medical Center • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC